Transrectal ultrasound-guided biopsy of the prostate: should warfarin be stopped before the procedure? Incidence of bleeding in a further 50 patients

Clinical Radiology

Volumn 61, Issue 12, 2006, Pages 1068-1069

  Halliwell, O T ^a   Lane, C ^a   Dewbury, K C ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

BLEEDING; CONTROLLED STUDY; DRUG WITHDRAWAL; HEMATURIA; HEMOSPERMIA; HOSPITAL ADMISSION; HUMAN; INCIDENCE; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSTATE BIOPSY; RECTUM HEMORRHAGE; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TRANSRECTAL ULTRASONOGRAPHY;

ANTICOAGULANTS; BIOPSY; HEMORRHAGE; HUMANS; MALE; PROSTATE; WARFARIN;

EID: 33750609295     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2006.07.011     Document Type: Letter

References (3)

1. Ihezue C.U., Smart J., Dewbury K.C., et al. Biopsy of the prostate guided by transrectal ultrasound: relation between warfarin use and incidence of bleeding complications. Clin Radiol 60 (2005) 459-463
2. Cochlin D.L. Biopsy of the prostate guided by transrectal ultrasound: relation between warfarin use and bleeding complications. Clin Radiol 60 (2005) 457-458
3. Ramachandran N., MacKinnon A., Allen C., et al. Biopsy of the prostate guided by transrectal ultrasound: relation between warfarin use and incidence of bleeding complications. Clin Radiol 60 (2005) 1130